Clinical
Reforms boost access to medical abortion
Removal of prescribing and dispensing restrictions on mifepristone linked to improved access through pharmacies, study reveals Ordering data show “a statistically significant and clinically meaningful increase in the number and …
Consultant recommendations: uncharted territory?
How does a pharmacist know whether their recommendations are making a difference? A poster presented at a recent conference takes a look A poster presented by accredited pharmacist Sarah Foster …
‘You can be waiting weeks and weeks… to hear anything back’
Pharmacists are testing a new model that allows the profession to virtually conduct medication safety checks at discharge, with GP access cited as a barrier Virtual pharmacists could provide vital …
WHO updates contraception guidelines
New recommendations cover OCP use for extended periods, and mifepristone as an additional emergency contraception option The World Health Organization (WHO) has released new guidelines that offer alternative ways of …
‘Emotionally demanding… but rewarding’
10 pharmacists reflect on their roles in voluntary assisted dying, citing concerns over inconsistent legislation, unpredictable workloads and remuneration Pharmacists have described the challenges and rewards of being involved in …
Positive signs on pharmacy naloxone supply and expertise
Naloxone supply in pharmacies is growing but more can be done, say experts Almost three quarters of Australian pharmacies are currently stocking naloxone, according to the findings of a recent …
Dynamics driving pharmacy-delivered vaccination explored
Study suggests assumptions about the relationship between pharmacy-administered vaccines and lower primary care access may not be correct Most pharmacy-delivered vaccinations over a recent five-year period took place within short …
Lack of remuneration a ‘major deterrent’: OCP study
Pharmacists strongly support contraceptive resupply, but some have concerns around independent prescribing, study finds Oral contraceptive resupply appears to be acceptable to community pharmacists, a qualitative study involving 24 pharmacist …
Women ‘often put their own healthcare last’
Pharmacist leader speaks on supporting women’s health by taking opportunities to ask about breathing changes Over the past week, Asthma Australia shone a light on women’s health as part of …
September MIMS update
Some recent changes to medicines listings, including new products, indications and contraindications New Products Remibrutinib (Rhapsido) is an oral Bruton’s tyrosine kinase (BTK) inhibitor. BTK is an intracellular protein selectively …
‘Women are already walking through our pharmacy doors’
Asthma is “largely absent” from women’s health conversations, warns a leading organisation, but one pharmacist believes bridging the gap starts with asking a very simple question Too many women put …
‘Overdose is an Australian problem’: Penington Institute
Access to lifesaving treatment, including naloxone and opioid replacement therapy “remains uneven”, as the number of overdose deaths hits a record high Findings from the 2026 edition of Australia’s Annual …